Guerbet SA (0ELV)
LSE
Closed
Oct 7, 2026
Day's Range
6.3752 wk Range
6.37Overview - 0ELV - Guerbet SA
Key Statistics
Valuation
Enterprise Value
409.35M
P/E (Trailing)
‪0.02‬
PEG Ratio
‪0.0011‬
Price / Sales (TTM)
‪0.0000090‬
Price / Book
‪0.33‬
EV / EBITDA
‪8.90‬
Profitability
Gross Margin
‪29.52%‬
Profit Margin
‪-13.56%‬
Operating Margin
‪-1.70%‬
Return on Assets
‪0.51%‬
Return on Equity
‪-34.57%‬
Ownership
Shares Outstanding
12.55M
Float
5.11M
Held by Insiders
‪63.21%‬
Held by Institutions
‪5.47%‬
Price stats
Beta
‪0.97‬
50-Day Avg
‪24.68‬
200-Day Avg
‪20.08‬
Dividends
Frequency
Annual
Market Cap - 0ELV - Guerbet SA
Peers - 0ELV - Guerbet SA
Peer Comparison
Compared with companies in Medical Devices listed on LSE.
- 0ELVLSEGuerbet SA90.11MMarket Cap-89.69%52-week change0.03P/E (Trailing)‪-13.56%‬Profit Margin
- SVSLSESavills PLC168.88BMarket Cap+6.10%52-week change22.09P/E (Trailing)‪2.49%‬Profit Margin
- 0Q15LSEAbbott Laboratories168.67BMarket Cap-38.26%52-week change45.46P/E (Trailing)‪12.91%‬Profit Margin
- 0Y6XLSEMedtronic plc118.72BMarket Cap-6.44%52-week change0.24P/E (Trailing)‪13.93%‬Profit Margin
- 0R2SLSEStryker Corp.102.51BMarket Cap-34.20%52-week change0.52P/E (Trailing)‪14.43%‬Profit Margin
- PRNLSEPrinces Group plc81.73BMarket Cap-42.22%52-week change23.86P/E (Trailing)‪1.90%‬Profit Margin
- 0RGTLSEDemant A/S76.63BMarket Cap+25.99%52-week change29.38P/E (Trailing)‪7.55%‬Profit Margin
Profile Summary - 0ELV - Guerbet SA
About
Guerbet SA is a French pharmaceutical group specializing in the research, development, production, and sale of contrast media for medical imaging. Founded in 1926 by André Guerbet, the company traces its roots to the discovery of Lipiodol, the first iodinated X-ray contrast agent in 1901. It offers a comprehensive…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
